ABSTRACT

Fact Sheet for Healthcare Providers: Quidel Corporation, Sofia 2 Flu + SARS Antigen FIA   [open pdf - 164KB]

From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Sofia 2 Flu + SARS [severe acute respiratory syndrome] Antigen FIA [fluorescent immunoassay]. The Sofia 2 Flu + SARS Antigen FIA is authorized for use with certain respiratory specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 [coronavirus disease 2019] by their healthcare provider within the first five days of the onset of symptoms."

Publisher:
Date:
2020-10-02
Series:
Copyright:
Public Domain
Retrieved From:
U.S. Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations